Online ISSN: 2515-8260

Keywords : Atrial Fibrillation


Interpretation of Epicardial Adipose Tissue Thicknessand Heart Disease in Atrial Fibrillation Patients

Mohamed Ahmed Abdalla Ebada, Aly Mohamed Abdelrahman, Ghada Ibrahim Mohamed, lam Galal Sayed

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 4474-4479

Background:Atrial fibrillation (AF) is commonly associated with overweight and obesity.
Overweight populations have higher incidence, prevalence, severity, and progression of AF
compared with their normal weight counterparts. Stable weight loss decreases AF burden and
AF recurrence following treatment.Epicardial adipose tissue (EAT) is a small but very
biologically active ectopic fat depot that surrounds the heart. Given its rapid metabolism,
thermogenic capacity, unique transcriptome, secretory profile, and simply measurability,
epicardial fat has drawn increasing attention among researchers attempting to elucidate its
putative role in health and cardiovascular diseases.

COMPARATIVE CHARACTERISTICS OF ANTICOAGULANTS AT ATRIAL FIBRILLATION IN COMORBID PATIENTS

Botir Daminov; Sherzod Abdullaev; Ranokhon Igamberdieva

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 2346-2352

Patients with Chronic Kidney Disease (CKD) develop a tendency to bleed and
thromboembolism, so the indication for anticoagulants at the attachment of atrial
fibrillation (AF) is complex. AF is the most common chronic heart arrhythmia, and
thromboembolism and ischemic stroke in particular are the main complications. In recent
years, new oral anticoagulants have been developed and they have shown superiority over
the classic antivitamin K anticoagulants in preventing the risk of stroke, systemic embolism
and bleeding, providing an effective alternative to these resources